semaglutide approval mash FDA Expands Novo Nordisk's Wegovy to the Fatty Liver Disease Novo Nordisk GLP-1 Drug Meets

Position statement

In a randomized, double-blind, placebo-controlled human trial, chronic supplementation with the NAD+ precursor nicotinamide riboside was well tolerated and effectively raised NAD+ metabolism in healthy middle-aged and older adults, with early signals toward lower blood pressure and arterial stiffness[1]

Patients using recovery-focused support monitor whether pain, soreness, or tendon irritation interferes less with training over time

Apixaban carries an FDA black-box warning for spinal/epidural hematoma risk in patients receiving neuraxial anesthesia or undergoing spinal procedures [1]

The letter describes a national ecosystem of counterfeit, contaminated and research-grade GLP-1s entering the U.S

Living with fibromyalgia over the long term can bring about a range of physical, emotional, and social effects